Skip to main content
Log in

Phase II trial of menogaril in advanced colorectal cancer

  • Clinical Studies
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

Menogaril, a new semisynthetic anthracycline antibiotic, was administered to 35 patients with advanced colorectal cancer. The drug was infused over 2 hr at a dose of 160 mg/sqm or 200 mg/sqm repeated every 4 weeks. Twenty-seven patients were evaluable for response and no objective responses were achieved. Myelosuppression, only leukopenia, was usually of mild-moderate degree and occurred in 63% of the patients. Twenty-seven percent of the patients experienced severe leukopenia. Local erythema and phlebitis were frequently observed and were severe in 13% of the patients. Nausea/vomiting (66%) and alopecia (50%) were of mild-moderate degree.

This study suggests that menogaril at these doses and schedule had no activity in advanced colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bhuyan BK, Neil GL, Li LH, McGovren JP, Wiley PF: Chemistry and biological activity of 7-con-O-methylnogaril (7-con-OMEN). In: ST Crooke, SD Reich (eds) Anthracyclines: Current Status and New Developments. Academic Press, New York 1980, pp 365–395

    Google Scholar 

  2. McGovren JP, Nelson KG, Lassus M, Cradock JC, Plowman J, Christopher JP: Menogaril: a new anthracycline agent entering clinical trials. Invest New Drugs 2:359–367, 1984

    Google Scholar 

  3. Dodion P, Sanders C, Rombaut W, Rozencweig M, Kitt MM, Kenis Y, Klastersky J: Activity of menogaril and N-demethylmenogaril in a human tumor cloning assay. Eur J Cancer Clin Oncol 22:245–249, 1986

    Google Scholar 

  4. Dodion P, Sessa C, Joss R, Crespeigne N, Willems Y, Kitt M, Abrams J, Finet C, Brewer JE, Adams WJ, Earhart RH, Rozencweig M, Kenis Y, Cavalli F: Phase I study of intravenous menogaril administered intermittently. J Clin Oncol 4:767–774, 1986

    Google Scholar 

  5. Dorr FA, Von Hoff DD, Kuhn JG, Schwartz R, Kisner DL: Phase I clinical investigation of 7-con-O-methylnogaril, a new anthracycline antibiotic. Cancer Res 46:2562–2565, 1986

    Google Scholar 

  6. Sigman LM, Van Echo DA, Egorin MJ, Whitacre MY, Aisner J: Phase I trial of menogaril administered as an intermittent daily infusion for 5 days. Cancer Treat Rep 70:721–725, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

for the EORTC Early Clinical Trials Group (EORTC/ECTG)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holdener, E.E., ten Bokkel Huinink, W.W., Decoster, G. et al. Phase II trial of menogaril in advanced colorectal cancer. Invest New Drugs 6, 227–230 (1988). https://doi.org/10.1007/BF00175404

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00175404

Key words

Navigation